Paula M. Hale

5.4k citations
43 papers · 4.2k indexed · 4 hit papers · h-index 19

Paula M. Hale

42 papers receiving 4.0k citations

Hit Papers

Liraglutide versus glimepiride monotherapy for type 2 dia...20082026201420202008200920132020250500750

Peers

Paula M. Hale
Comparison fields: 5 of 108
  • Endocrinology, Diabetes and Metabolism 3.4k
  • Molecular Biology 1.6k
  • Pharmacology 1.4k
  • Surgery 1.2k
  • Physiology 708
Replace Sue D. Pedersen with:
Sue D. Pedersen Canada
Salvatore Calanna Denmark
Domenica Rubino United States
Christine B. Jensen Denmark
Ole Kleist Jeppesen Denmark
Niels Zeuthen Denmark
Marie Thi Dao Tran Denmark
Nadia N. Ahmad United States
Mathijs C. Bunck United States
Lisa Connery United States
Paula M. Hale relative to Sue D. Pedersen Canada Sue D. Pedersen's profile →
Citations per field
00.5×5.2×
Sue D. Pedersen · 1×
Citations per year

Countries citing papers authored by Paula M. Hale

Since Specialization
Citations

This map shows the geographic impact of Paula M. Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula M. Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula M. Hale more than expected).

Fields of papers citing papers by Paula M. Hale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula M. Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula M. Hale. The network helps show where Paula M. Hale may publish in the future.

Co-authorship network of co-authors of Paula M. Hale

This figure shows the co-authorship network connecting the top 25 collaborators of Paula M. Hale. A scholar is included among the top collaborators of Paula M. Hale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula M. Hale. Paula M. Hale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 15
4 222
5 66
6 87
7 4
8 85
9 156
10
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230))
240
11 60
12
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)breakdown →
707
13
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trialbreakdown →
882
14 24
15 60
16 2
17 17
18 18
19 9
20 16

About Paula M. Hale

Paula M. Hale is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Gastroenterology, having authored 43 papers that have together received 4.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (26 papers), Metabolism, Diabetes, and Cancer (18 papers) and Pharmacology and Obesity Treatment (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.4k citations), Pharmacology (1.4k citations) and Endocrine and Autonomic Systems (199 citations). Paula M. Hale has collaborated with scholars based in United States, Denmark and New Zealand. Frequent co-authors include Milan Zdravkovic, Bruce W. Bode, Robert E. Ratner, Robert R. Henry, Philip Raskin, Lawrence Blonde, Pedro Alberto García-Hernández, John B. Buse, Alan J. Garber and Priscilla Hollander. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026